CEO of Providence Therapeutics Brad Sorenson talks about the company’s clinical trials for a made-in-Canada vaccine and how results could bring new hope for Canada’s vaccine shortage problem.
Global News Morning Toronto
How a made-in-Canada vaccine could bring hope for vaccine shortages
More Videos
-
Toronto Fire Chief reflects on a year of challenges, rescues and resilience
-
Holiday hosting hacks to save time and stress
-
Crime Stoppers unveils 2026 police K-9 calendar
-
Science News Now: Unveiling new discoveries
-
New rules for carbon monoxide detectors in Ontario
-
Creative holiday gift wrapping ideas that stand out
You are viewing an Accelerated Mobile Webpage.
View Original Article